VERVE-101 - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of liquefied natural gas (LNG) storage tanks and carrier vessels, reflecting NextDecade’s Rio Grande LNG expansion and long-term offtake deals.

Venture Global (NYSE: VG) and Edison settle Calcasieu Pass arbitration, agree to expand LNG deliveries to Italy

Herald Investment Trust (LSE: HRI) board races to build cash war chest as Saba standoff stretches into spring

Alembic Pharmaceuticals (APLLTD) wins FDA final approval for Paroxetine Extended-Release Tablets

ABIONYX Pharma (ABNX) achieves sphingomyelin manufacturing breakthrough to advance CER-001 sepsis program

Representative image of PCSK9 inhibitor drug development across leading pharmaceutical companies in 2025

Read More

5 minute read

Pharma Industry News

Top 5 PCSK9 inhibitor stocks to watch in 2025: From injectables to gene editing

Explore the top five PCSK9 inhibitor stocks—Amgen, Regeneron–Sanofi, Merck, Novartis, Verve—and what makes each a standout in cholesterol treatment in 2025.

byPallavi Madhiraju

June 11, 2025

web analytics